Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 17.3B |
| Enterprise Value | 18.06B |
| P/E Ratio | 70.56 |
| PEG Ratio | -1.41 |
| Price/Sales Ratio | 2.34 |
| Price/Book Ratio | 1.21 |
| Enterprise/Revenue | 2.61 |
| Enterprise/EBITDA | 16.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 5.48B |
| Revenue/Share | 3.57 |
| Gross Profit | 1.74B |
| EBITDA | 846.59M |
| Net Income | 349.49M |
| Diluted EPS | 0.24 |
Balance Sheet
| Total Cash | 3.55B |
| Total Cash/Share | 2.42 |
| Total Debt | 2.93B |
| Total Debt/Equity | 0.25 |
| Current Ratio | 2.31 |
| Book Value Per Share | 8.19 |
Price History
| 52-Week Change | -17.02 |
| 52-Week High | 12.68 |
| 52-Week Low | 8.5 |
| Moving Average 50 Days | 9.96 |
| Moving Average 200 Days | 10.73 |
Statistics
| Average Volume | 6.29M |
| Shares Outstanding | 1.25B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.14 |
| Trailing Annual Dividend Yield | 1.47 |
| Payout Ratio | 1.22 |
| Last Split Factor | 8:5 |
| Last Split Date | June 13, 2016 |
AD
